Xencor, Inc. (XNCR): Price and Financial Metrics

XNCR POWR Grades

• XNCR scores best on the Sentiment dimension, with a Sentiment rank ahead of 74.69% of US stocks.
• XNCR's strongest trending metric is Stability; it's been moving down over the last 179 days.
• XNCR's current lowest rank is in the Momentum metric (where it is better than 8.18% of US stocks).

XNCR Stock Summary

• Of note is the ratio of Xencor Inc's sales and general administrative expense to its total operating expenses; merely 6.52% of US stocks have a lower such ratio.
• With a year-over-year growth in debt of 192.13%, Xencor Inc's debt growth rate surpasses 94.24% of about US stocks.
• Revenue growth over the past 12 months for Xencor Inc comes in at 124.23%, a number that bests 93.29% of the US stocks we're tracking.
• If you're looking for stocks that are quantitatively similar to Xencor Inc, a group of peers worth examining would be RCUS, INBX, ATRA, MRTX, and ARCT.
• Visit XNCR's SEC page to see the company's official filings. To visit the company's web site, go to www.xencor.com.

XNCR Valuation Summary

• XNCR's EV/EBIT ratio is 79.3; this is 170.65% higher than that of the median Healthcare stock.
• XNCR's EV/EBIT ratio has moved up 83.4 over the prior 94 months.
• Over the past 94 months, XNCR's EV/EBIT ratio has gone up 83.4.

Below are key valuation metrics over time for XNCR.

XNCR Growth Metrics

The 3 year net income to common stockholders growth rate now stands at 323%.
• The 2 year revenue growth rate now stands at 145.92%.
• Its 2 year cash and equivalents growth rate is now at -70.66%.

XNCR's revenue has moved up $241,588,000 over the prior 70 months.

The table below shows XNCR's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	275.111	-16.853	82.631
2021-09-30	162.949	-61.559	-4.121
2021-06-30	178.632	-26.402	23.52
2021-03-31	124.274	-44.43	-63.746
2020-12-31	122.694	-5.004	-69.333
2020-09-30	84.356	-41.665	-82.554

XNCR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• XNCR has a Quality Grade of D, ranking ahead of 9.2% of graded US stocks.
• XNCR's asset turnover comes in at 0.261 -- ranking 167th of 682 Pharmaceutical Products stocks.
• PTGX, MDWD, and ALBO are the stocks whose asset turnover ratios are most correlated with XNCR.

The table below shows XNCR's key quality metrics over time.